Application of digital medical technologies in percutaneous transhepatic cholangioscopy lithotripsy for the treatment of hepatolithiasis
10.3760/cma.j.issn.1673-9752.2013.05.008
- VernacularTitle:数字医学技术在经皮肝胆道镜碎石治疗肝胆管结石病中的应用
- Author:
Ping WANG
;
Xiaowu CHEN
;
Chihua FANG
;
Kangning LUO
;
Yingfang FAN
- Publication Type:Journal Article
- Keywords:
Hepatolithiasis;
Digital medicine;
Choledochoescopy
- From:
Chinese Journal of Digestive Surgery
2013;(5):352-357
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of medical image-three dimensional visible system (MI-3DVS) in percutaneous transhepatic cholangioscopy lithotripsy (PTCSL) for the treatment of hepatolithiasis.Methods The clinical data of 66 patients with hepatolithiasis (55 were from the First People's Hospital of Shunde City and 11 were from the Zhujiang Hospital) were retrospectively analyzed.The images of computed tomography were three-dimensionally reconstructed with MI-3DVS.The location,number,size,shape of the stones were figured out,and the operation strategies of PTCSL were designed according to the types of the disease.The clinical value of MI-3DVS was evaluated according to the operation results and postoperative recovery of patients.All the patients were followed up via telephone or out-patient re-examination.Results Liver,biliary system,stones and blood vessels were three-dimensionally reconstructed with the MI-3 DVS,and the size,number,shape,location of the stones and location,degree,length of the biliary stricture and its anatomical relationship with adjacent blood vessels were clearly displayed.The coincidence rate of planned and actual operations was 95.5％ (63/66).The mean operation time,intraoperative blood loss,rate of stone clearance,complication rate and duration of hospital stay of 63 patients were (117 ± 9) minutes,(18 ± 1) ml,92.4％ (61/66),6.1％ (4/66) and (15 ± 4) days,respectively.All the patients were followed up till September 2012,the median survival time was 16 months (range,1-69 months),and the recurrence rate of hepatolithiasis was 9.1％ (6/66).One patient died of tumor metastasis and multi-organ dysfunction syndrome postoperatively.Conclusion MI-3DVS could effectively improve the safety and efficiency of PTCSL for patients with hepatolithiasis.
